Biological Information
Background Information:
The acetylation state of histones is dependent on the activity of two proteins, histone acetyltransferase and histone deacetylase (HDAC), which acetylate and deacetylate histones, respectively. The human HDAC proteins are organized into classes based on their similarity to yeast HDAC proteins. Class I HDACs include HDAC1, HDAC2, HDAC3, and HDAC8, which are homologous to the yeast Rpd3 protein. Class II HDACs are similar to yeast HDA1 and include HDAC4, HDAC5, HDAC6, HDAC7, and HDAC9. Histone deacetylase inhibitors may induce apoptosis and find use as treatment for hematological malignancies.
Family:
Epigenetic
Sub Family:
Histone Deacetylase (HDAC)
Class:
Eraser
Protein Name:
HDAC8
Uniprot Number:
Q9BY41
Gene Name:
HDAC8
Gene ID:
55869
Gene Aliases:
RPD3
Accession Number:
NM_018486
Organism:
Human
Construct Details:
Recombinant
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Antagonist
Detection Method:
Fluorimetry
Measured Response:
Fluorescence
Testing Information
Substrate:
fluorogenic HDAC substrate (400 µM)
Incubation:
60 min at RT
Control Inhibitor:
Trichostatin A
Test Concentration / Dose:
Eurofins will provide IC/EC50 calculation if 5 or more concentrations are selected.
Test Sample Requirements:
Minimum for 1) Screen: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed) for 10µM final testing. 2) Dose Response: 90 μl of 10 mM stock -OR- 1 mg (pre-weighed) for a top concentration at 10 µM.
Minimum Order Quantity:
10
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Additional Information
Brand:
LeadHunter
Testing Location:
France - Celle L'Evescault